Sign In
Buy VRTX
$428.34
+3.25 (+0.765%)
At Close: Jun 03, 2026
Graphene Investments SAS Boosts Stake in Vertex Pharmaceuticals Incorporated $VRTX
06:14am, Wednesday, 17'th Dec 2025
Graphene Investments SAS increased its stake in shares of Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) by 22.1% during the third quarter, according to its most recent Form 13F filing with the Se
Corient Private Wealth LLC Cuts Stock Holdings in Vertex Pharmaceuticals Incorporated $VRTX
04:56am, Wednesday, 17'th Dec 2025
Corient Private Wealth LLC reduced its stake in Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) by 3.5% during the undefined quarter, according to the company in its most recent Form 13F filing wit
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Receives Average Rating of “Moderate Buy” from Analysts
01:58am, Wednesday, 17'th Dec 2025
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX - Get Free Report) has been assigned an average rating of "Moderate Buy" from the twenty-eight analysts that are currently covering the stock, MarketB
12 Days of Investing: My Top 12 Stocks to Buy Before 2026
11:10am, Monday, 15'th Dec 2025
There are only 12 investing days left in 2025. Now is a great time to load up on stocks that may win next year -- and over time.
Castleark Management LLC Cuts Stock Holdings in Vertex Pharmaceuticals Incorporated $VRTX
04:06am, Monday, 15'th Dec 2025
Castleark Management LLC trimmed its stake in Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) by 98.4% during the undefined quarter, according to the company in its most recent disclosure with the
Ameriprise Financial Inc. Sells 54,107 Shares of Vertex Pharmaceuticals Incorporated $VRTX
04:10am, Saturday, 13'th Dec 2025
Ameriprise Financial Inc. lowered its holdings in shares of Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) by 2.4% in the undefined quarter, according to its most recent disclosure with the SEC. T
Investors Heavily Search Vertex Pharmaceuticals Incorporated (VRTX): Here is What You Need to Know
10:00am, Friday, 12'th Dec 2025
Vertex (VRTX) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
3 Brilliant Growth Stocks to Buy Now and Hold for the Long Term
02:44am, Friday, 12'th Dec 2025
Apple's fiercely loyal customer base gives it a built-in market for any new devices it might launch in the future. MercadoLibre is positioned to grow rapidly in the Latin America e-commerce and fintec
Why Vertex Pharmaceuticals (VRTX) is a Top Momentum Stock for the Long-Term
10:51am, Monday, 08'th Dec 2025
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Disney, Nu Holdings, Phillips 66 And A Health Care Stock On CNBC's 'Final Trades'
10:44am, Monday, 08'th Dec 2025
Nu Holdings, Phillips 66, Vertex Pharmaceuticals and Disney get shoutouts on CNBC's "Halftime Report Final Trades."
Federated Hermes Inc. Acquires 23,726 Shares of Vertex Pharmaceuticals Incorporated $VRTX
05:03am, Monday, 08'th Dec 2025
Federated Hermes Inc. boosted its holdings in Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) by 13.9% in the second quarter, according to the company in its most recent 13F filing with the SEC. Th
Cerity Partners LLC Purchases 10,768 Shares of Vertex Pharmaceuticals Incorporated $VRTX
04:21am, Sunday, 07'th Dec 2025
Cerity Partners LLC boosted its position in Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) by 4.3% in the undefined quarter, according to its most recent filing with the SEC. The fund owned 263,69
Down 10%, Should You Buy the Dip on Vertex Pharmaceuticals?
07:15pm, Saturday, 06'th Dec 2025
Vertex Pharmaceuticals is the worldwide leader in cystic fibrosis treatment -- and its drugs have generated blockbuster revenue. The company has expanded into other therapeutic areas in recent years a
Vertex's gene therapy shows promise in younger children with blood disorders
07:04am, Saturday, 06'th Dec 2025
Vertex Pharmaceuticals said on Saturday its gene therapy helped children aged between 5 and 11 years with sickle cell disease to be free of painful events and allowed those with another blood disorder
BOSTON--(BUSINESS WIRE)--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced data from multiple studies demonstrating the clinical benefits of CASGEVY® (exagamglogene autotemcel) in pe
